NewsCura

Cebu Landmasters, Inc.

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked
Price
2.1900
Trading status
Normal
Recommendation
Hold (dirt cheap but leveraged; wait for cash flow and debt to turn)Hold
Committee call
Sell
Indices
None

Analysis

CLI - Cebu Landmasters, Inc.

One-line summary: dominant Visayas-Mindanao residential developer trading at a distress-level P/E and P/B despite growing reservation sales, funded by rising debt and negative operating cash flow in three of the last five years.

Snapshot

Reviewed July 19, 2026
Index membership None
Price at review P2.19
Recommendation Hold (statistically dirt cheap, but real balance-sheet risk; not a starter Buy at face value, not a Sell if already owned)
Market cap P7.59B (3.47B shares)
Trailing P/E ~2.96x
Estimated forward P/E ~2.5-3x (core earnings guided flat to slightly up ex one-offs)
Dividend (2026) P0.18/share, ~8.2% yield at 2.19 (flat since 2023; ex-date April 21, 2026, paid May 6, 2026)
P/B ~0.21 (book value ~P10.5/share; ~0.32 on tangible book value)
Debt D/E 1.73, Debt/EBITDA 8.24x, ~P63.2B total debt vs ~P4.2B cash

Revenue and earnings trend

Revenue: P11.16B (2021), P15.66B (2022), P18.82B (2023), P18.65B (2024), P18.52B (2025), P19.53B trailing twelve months. Growth has effectively plateaued around P18-19B since 2023, even as reservation sales (bookings, not recognized revenue) kept climbing to a record P24.6B in 2025 (+45.6%). The gap exists because CLI recognizes revenue on construction progress, not on the reservation date, so there is a multi-quarter lag between a strong bookings year and the revenue eventually reported.

Net income (attributable to parent, matching the EPS base): P2.61B (2021), P2.69B (2022), P2.80B (2023), P3.01B (2024), P3.04B (2025), P2.92B trailing twelve months (-3.5% YoY). Q1 2026 net income fell 24% to P1.0B (P881M attributable to parent) purely because Q1 2025 included a one-off ~P900M gain from an investment property sale; management says core operations were actually stronger excluding that item. EPS has been choppy rather than a clean uptrend: P0.78 (2022), P0.81 (2023), P0.72 (2024), P0.78 (2025), P0.75 trailing.

Note: press coverage of the FY2025 results (Manila Bulletin) cited a "record" P4.03B net income, materially higher than the P3.04B figure above. The P4.03B figure appears to be gross consolidated net income before minority/JV partners' share; the P3.04B figure (used here, consistent with reported EPS) is net income attributable to parent shareholders, the number that actually drives per-share value. Worth flagging since headline press releases lead with the bigger number.

VisMin dominance, recurring income, and Luzon expansion

CLI is the #1 residential developer in Visayas-Mindanao with an 18-19% market share across 132 projects in 18 VisMin cities (2025 Colliers market study). Landbank expanded to 188 hectares, up 300% year on year, including a new 79-hectare township site in Liloan, Cebu; management pegs the existing landbank at roughly P300B of prospective project value over the next 7-8 years, a long runway if funding and execution hold up.

Recurring income (hotel, leasing, management fees) is still small, about P735M or roughly 4% of 2025 revenue, but growing fast: hotel revenue +79%, leasing +40%, management fees +21%. That is a healthy diversification away from pure development-sale cyclicality, though it will take years to become a material offset if the core residential business slows.

CLI made its first NCR move in 2026 (a Pasig development site) and picked up a 70-hectare Cavite parcel for a future township, its first steps outside VisMin. This coincides with a leadership transition: Jose Franco Soberano became President and CEO, succeeding founder Jose R. Soberano III, who moves to Executive Chairman. Family control continues and the succession looks orderly so far, but it is a concentration-of-control point worth tracking, especially while the company is simultaneously taking on new geography and new leverage. The 2026 launch pipeline (20+ projects, ~P48B inventory value, ~9,600 units) has already slipped into early 2027 on permitting delays, a reminder that launch schedules routinely move.

Dividend sustainability

The dividend has been flat at P0.18/share since 2023 (up from P0.15 in 2022), a modest track record rather than a growth story. Measured against earnings, the payout is conservative: 14.9% (2021), 22.3% (2022), 26.0% (2023), 35.7% (2024), 31.7% (2025), ~33% currently, so the dividend is well covered by accounting profit.

Measured against free cash flow, coverage is a different story. FCF was negative in three of the last five years (2021, 2023, 2025), meaning the entire dividend paid in those years (P389M to P963M) came out of debt or working-capital drawdown, not cash generated by the business. As long as the earnings payout ratio stays in the 25-35% band and lenders keep extending credit, the current peso dividend looks safe near-term. It is a leverage-supported dividend during growth years, not a self-funding one, and that distinction matters if credit conditions tighten.

ROE

ROE has trended down: 15.96% (2021), 16.58% (2022), 17.87% (2023, the peak), 14.87% (2024), 12.39% (2025), 11.01% trailing. CLI is widely cited in Philippine property circles as running the highest ROE among the major listed developers, a reputation earned in 2022-2023; on current numbers that gap has narrowed materially. A clean, verifiable side-by-side ROE comparison against Ayala Land, SM Prime, Vista Land, and Robinsons Land was not found in public sources during this review, so treat "highest ROE in the sector" as a directional, not confirmed, claim for 2025-2026.

What is verifiable: CLI's own ROE is now roughly two-thirds of its 2023 peak. Unlike a shrinking-earnings ROE collapse, this decline is driven mostly by book value (equity) growing faster than net income, book value per share is now around P10.5. That is a healthier form of ROE dilution than an earnings collapse, but it is dilution of per-share earning power nonetheless.

Free cash flow and balance sheet

Operating cash flow has been negative in three of the last five years, a pattern common to Philippine developers who recognize revenue on percentage-of-completion while spending cash upfront on land and construction:

2021 2022 2023 2024 2025
Operating cash flow -P0.92B P1.29B -P3.55B P4.25B -P3.98B
Capex -P0.30B -P1.20B -P1.15B -P1.54B -P1.51B
Free cash flow -P1.22B P0.09B -P4.70B P2.71B -P5.49B
Dividends paid -P0.39B -P0.60B -P0.73B -P1.07B -P0.96B

2025's -P5.49B FCF is the worst year in this window, coinciding with the 300% landbank expansion and a jump in trade and other receivables (+128% YoY to P10.5B) and real estate inventories (+67% to P21.8B) reported through the first nine months of 2025. This is a company plowing cash into future supply faster than it collects cash from current sales, funded by roughly P19.17B in new bank borrowings in the first nine months of 2025 (+10% YoY) plus an active P15B debt securities program (three tranches of sustainability-linked bonds/notes issued 2024-2026, rated PRS Aa+ stable by Philippine Rating Services Corp).

Total debt stands at roughly P63.2B against roughly P4.2B cash (of the P63.2B, about P44.85B was bank loans as of September 2025, the rest is the bond/notes program). That works out to a debt/equity of 1.73x and a debt/EBITDA of 8.24x, both materially higher than the sector's blue-chip names. The stock's own Altman Z-Score sits at 0.83, deep in the conventional "distress" zone (below 1.8). Altman Z-Score models are a poor fit for capital-intensive property developers generally (most PH developers, including larger, safer names, also screen weak on this specific model), so treat it as a flag to keep watching rather than a standalone sell signal, but it is not a number to wave away either.

Capital allocation

Management is plowing capital into landbank and new project launches rather than into recurring income at scale or buybacks. Capex guidance for 2026 is inconsistent across recent coverage (BusinessWorld's FY2025 recap cited a P12-14B budget, down from P16B in 2025; a later report tied to the Q1 2026 results cited P20B for 2026); directionally capex is being maintained or increased, not harvested down. No buybacks have been reported. The dividend remains a small, disciplined slice of earnings (~33% payout) rather than a near-total payout.

Debt funds most of the growth: the P15B bond program (three tranches through 2025-2026) and roughly P19.17B in new 2025 bank borrowings are earmarked for project development and refinancing 2025 maturities. This is a growth-stage capital allocation profile: a bet that borrowed money against a 7-8 year, ~P300B landbank pipeline and a first Luzon entry pays off. It works if reservation-to-revenue conversion and collections keep pace with obligations; it is a real risk if construction-cost inflation, interest rates, or VisMin demand turn against the company at the same time debt service comes due.

Verdict at P2.19 (July 19, 2026)

Hold. At a trailing P/E of roughly 2.96x and a P/B of roughly 0.21x, CLI is priced as though it were in genuine distress: book value alone is close to 5x the share price, and the company is still profitable, still the #1 VisMin residential developer, still paying a covered dividend (33% of earnings), and still growing reservation sales and recurring income at double-digit rates. That combination is unusual and explains why the stock keeps coming up in value screens.

But the market is not obviously wrong to price it this way. Operating cash flow was negative in three of the last five years, FCF was -P5.49B in 2025 alone, debt/EBITDA sits at 8.24x, and the stock's own Altman Z-Score of 0.83 flags balance-sheet distress risk under that model. ROE has fallen from an 18% peak to roughly 11-12%, and per-share earning power has been diluted even as headline numbers hold up. This reads less like a classic "value trap" (where earnings are about to fall off a cliff, as with GMA7) and more like a leveraged growth bet: CLI needs its landbank and Luzon expansion to convert into cash faster than its bond and bank obligations come due. That could work out well for shareholders, or it could not. At the current price it is not compelling enough as a fresh Buy given the verifiable leverage and cash-flow red flags, but the covered dividend, real earnings, and market leadership are not a reason to sell an existing position either.

What would change the call:

  • Buy trigger: debt/EBITDA falls toward 5-6x and operating cash flow turns positive for two consecutive years, confirming the 2025 landbank-driven cash burn was temporary rather than structural, or the payout ratio stays under 40% of earnings while the per-share dividend resumes growth off its P0.18 plateau.
  • Sell trigger: a bond covenant breach, credit rating downgrade, or missed coupon or maturity payment, or operating cash flow negative for a third straight year running into 2026-2027, or the dividend cut or suspended, or reservation sales growth reversing (currently +45.6%), signaling the VisMin/Luzon demand story is cracking.

No trigger has fired this week: no covenant breach, downgrade, missed payment, dividend change, or reversal in reservation sales has been reported. Q2 2026 results have not been published yet.

CLI is a small cap (~P7.59B market cap) trading in a tight 52-week range (P2.08-P2.60) on thin volume; exits can be slow and slippage on size matters. VisMin concentration is easing with the Luzon entry but still dominates the book, and family control (Soberano family) continues through a recent, so far orderly, generational leadership transition. Analysis, not financial advice.

Committee review (July 19, 2026)

Five investor lenses judged the page's facts independently, each confined to its own framework.

Lens Signal Confidence Core argument
Ben Graham Bearish 70 Debt/equity 1.73x, debt/EBITDA 8.24x, and an Altman Z-Score of 0.83 fail the margin-of-safety test outright, and free cash flow negative in three of five years disqualifies the stock regardless of the cheap 2.96x P/E or 0.21x P/B.
Warren Buffett Bearish 78 ROE fell from a 17.87% peak (2023) to 11.01% TTM even as book value kept climbing, the opposite of capital-light compounding, and rising bank borrowings (P19.17B in nine months of 2025) are propping up the 33% payout, not owner earnings.
Michael Burry Bearish 78 FCF was negative in three of five years (-P4.70B in 2023, -P5.49B in 2025), the flat P0.18 dividend was funded by new debt not earnings, and the Manila Bulletin's P4.03B headline net income versus the real P3.04B attributable figure is the accounting-versus-narrative gap Burry hunts for.
Nassim Taleb Bearish 78 Debt/EBITDA 8.24x, debt/equity 1.73x, and an Altman Z-Score of 0.83 plus a debt-funded dividend during three cash-negative years is textbook fragility; the payoff is capped on the upside (cheap P/E) and open-ended on the downside if refinancing conditions tighten.
Stanley Druckenmiller Neutral 45 Deep value means nothing without a catalyst, and the Luzon pivot and P24.6B bookings won't hit earnings for years while the 2026 launch pipeline has already slipped to 2027; no index inclusion means no flow-driven repricing either.

Conferred call: Sell (4 bearish, 1 neutral, unchanged from July 12). The committee remains more bearish than the page's Hold: balance-sheet risk (debt/EBITDA 8.24x, negative FCF in three of five years) still outweighs the statistical cheapness in every lens, and Druckenmiller's neutral read still concedes there's no catalyst. It lines up with [[stock-trading-strategy-and-rules]] rule 15 (avoid buying purely because a stock sits near a 52-week low, that's a trap not a catalyst): CLI trades at 2.19 against a 2.08-2.60 range with no confirmed setup or catalyst, so the Hold call here should not be read as an invitation to add, only to leave existing positions alone. Shared flip trigger: all five lenses converge on the same test: two consecutive years of positive free cash flow without fresh debt funding the growth (Graham and Buffett add debt/equity or debt/EBITDA coming down meaningfully alongside it).

Review history

Date Price Recommendation
July 10, 2026 2.14 Hold (speculative interest only, not a starter Buy)
July 12, 2026 2.14 Hold (unchanged; committee conferred call is Sell, see Committee review)
July 19, 2026 2.19 Hold (unchanged; no triggers fired; committee conferred call remains Sell)

Sources